4//SEC Filing
Shukla Sath 4
Accession 0000899243-22-004593
CIK 0001701108other
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 4:19 PM ET
Size
11.6 KB
Accession
0000899243-22-004593
Insider Transaction Report
Form 4
Shukla Sath
CEO & President
Transactions
- Award
Common Stock
2022-02-01+38,014→ 62,081 total - Award
Stock Option (Right to Buy)
2022-02-01+53,190→ 53,190 totalExercise: $11.18Exp: 2032-02-01→ Common Stock (53,190 underlying)
Footnotes (3)
- [F1]Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in four equal annual installments beginning on February 1, 2023, subject to the Reporting Person's continued service through the applicable vesting date.
- [F2]Consists of 62,081 RSUs held by the Reporting Person.
- [F3]The shares underlying this option vest as to 25% on February 1, 2023, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.
Issuer
Spero Therapeutics, Inc.
CIK 0001701108
Entity typeother
Related Parties
1- filerCIK 0001782817
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 4:19 PM ET
- Size
- 11.6 KB